within Pharmacolibrary.Drugs.ATC.G;

model G03DA04_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00119,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.013800000000000002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0856,
    k12             = 87.7,
    k21             = 87.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03DA04_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Progesterone is a natural steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis. It is used as a medication primarily for hormone replacement therapy, treatment of menstrual disorders, and as a component of hormonal contraceptives. Progesterone is approved for use today in various oral, vaginal, and injectable forms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult women after a single intravenous bolus dose administration.</p><h4>References</h4><ol><li><p>Zhao, J, et al., &amp; Jin, F (2017). Formulation, Optimization, Characterization, and Pharmacokinetics of Progesterone Intravenous Lipid Emulsion for Traumatic Brain Injury Therapy. <i>AAPS PharmSciTech</i> 18(5) 1475–1487. DOI:<a href=\"https://doi.org/10.1208/s12249-016-0637-5\">10.1208/s12249-016-0637-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27796907/\">https://pubmed.ncbi.nlm.nih.gov/27796907</a></p></li><li><p>Gangrade, NK, et al., &amp; Price, JC (1992). Pharmacokinetics of progesterone in ovariectomized rats after single dose intravenous administration. <i>Biopharmaceutics &amp; drug disposition</i> 13(9) 703–709. DOI:<a href=\"https://doi.org/10.1002/bdd.2510130908\">10.1002/bdd.2510130908</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1467457/\">https://pubmed.ncbi.nlm.nih.gov/1467457</a></p></li><li><p>Ma, J, et al., &amp; Zeng, Y (2016). Progesterone for acute traumatic brain injury. <i>The Cochrane database of systematic reviews</i> 12(12) CD008409–None. DOI:<a href=\"https://doi.org/10.1002/14651858.CD008409.pub4\">10.1002/14651858.CD008409.pub4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28005271/\">https://pubmed.ncbi.nlm.nih.gov/28005271</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03DA04_1;
